|Nigel Key, MBChB, FRCP||Executive Leadership|
|Barbara Konkle, MD||Executive Leadership|
|Kristy Lee, MS, CGC||Coordinator|
|Leighton Telling, BS||Coordinator|
|Justyne E. Ross, Ph.D.||Member|
|Shruthi Mohan, Ph.D.||Member|
|Kate Downes, PhD||Member|
|Valerie Trapp-Stamborski, PhD||Member|
|Connie Miller, PhD||Member|
|Manuel Carcao, MD||Member|
|Jamie McCreery, MS, CGC||Member|
|Bhavya Doshi, MD||Member|
|Amanda Payne, MPH||Member|
|Frank Leebeek, MD, PhD||Member|
Please contact a coordinator if you have questions.
A systematic process of evaluating evidence to classify a genomic variant on a spectrum from pathogenic to benign with respect to a particular disease and inheritance pattern.